The Irish Competition Authority clears the first otherwise anticompetitive merger using the failing firm defence (Baxter / Fannin)

Introduction 1 On 21 October 2015 the Competition and Consumer Protection Commission (CCPC), Ireland’s competition agency, cleared the acquisition by Baxter Healthcare Limited (Baxter) of Fannin Compounding Limited (Fannin), a business division of Fannin Limited which was, in turn, a subsidiary of DCC Vital Limited. [1] The transaction was notified to the CCPC on 9 June 2015, Phase II initiated on 3 September 2015. There was no appeal on the CCPC’s decision. [2] 2 The CCPC has cleared an otherwise anticompetitive merger using the failing firm defence. [3] In earlier CCPC merger determinations the CCPC had either decided that the four cumulative failing firm conditions were not all satisfied [4] or cleared the merger on the grounds it did not lead to a substantially lessening of

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

  • Trinity College Dublin

Citation

Paul Gorecki, The Irish Competition Authority clears the first otherwise anticompetitive merger using the failing firm defence (Baxter / Fannin), 21 octobre 2015, e-Competitions Due Process Research Program, Art. N° 92303

Visites 97

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues